Edwards Lifesciences Corporation Deferred Income Tax Expense (Benefit)
Edwards Lifesciences Corporation (EW) reported Deferred Income Tax Expense (Benefit) of -$65.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-25
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for the quarter ending 2010-12-31 was $900.00K, a 60.87% decline year-over-year.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for the quarter ending 2010-09-30 was -$2.60M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for the quarter ending 2009-12-31 was $2.30M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for the quarter ending 2009-09-30 was -$4.90M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for fiscal 2025 was -$65.80M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for fiscal 2024 was -$162.80M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for fiscal 2023 was -$242.40M.
- Edwards Lifesciences Corporation deferred income tax expense (benefit) for fiscal 2022 was -$261.70M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$65.80M 10-K · filed 2026-02-25 | ||||
| 2024-12-31 | -$162.80M 10-K · filed 2026-02-25 | ||||
| 2023-12-31 | -$242.40M 10-K · filed 2026-02-25 | -$262.00M 10-K · filed 2024-02-12 | |||
| 2022-12-31 | -$261.70M 10-K · filed 2025-02-28 | -$250.90M 10-K · filed 2023-02-13 | |||
| 2021-12-31 | -$44.00M 10-K · filed 2024-02-12 | ||||
| 2020-12-31 | -$52.20M 10-K · filed 2023-02-13 | ||||
| 2019-12-31 | $10.50M 10-K · filed 2022-02-14 | ||||
| 2018-12-31 | -$21.20M 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | $27.10M 10-K · filed 2020-02-14 | ||||
| 2016-12-31 | -$24.50M 10-K · filed 2019-02-15 | ||||
| 2015-12-31 | -$15.80M 10-K · filed 2018-02-16 | ||||
| 2014-12-31 | -$66.70M 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | $46.00M 10-K · filed 2016-02-19 | $47.50M 10-K · filed 2014-02-28 | |||
| 2012-12-31 | -$28.00M 10-K · filed 2015-02-20 | -$26.80M 10-K · filed 2013-02-28 | |||
| 2011-12-31 | -$10.20M 10-K · filed 2014-02-28 | ||||
| 2010-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$1.70M derived: sum of 2 quarters · filed 2013-02-28 | -$5.90M 10-K · filed 2013-02-28 | ||
| 2010-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$6.80M 10-Q · filed 2010-11-08 | |||
| 2010-06-30 | -$4.20M 10-Q · filed 2010-08-06 | ||||
| 2009-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$2.60M derived: sum of 2 quarters · filed 2012-02-27 | -$2.00M 10-K · filed 2012-02-27 | ||
| 2009-09-30 | -$4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$4.30M 10-Q · filed 2010-11-08 | |||
| 2009-06-30 | $600.00K 10-Q · filed 2010-08-06 | ||||
| 2008-12-31 | -$20.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |